The samX platform is ideally suited to the study of native membrane proteins and protein complexes such as the 7TM G-Protein Coupled Receptors (GPCRs), either as membrane fragments or within liposome or vesicle particles. Such complexes can be very challenging to analyse by traditional biosensor platforms. For these therapeutically relevant targets, samX technology represents a new potential tool for drug discovery programmes.
Closely coupled to this, many drug companies are also interested in looking at the separate conformational data from the samX platform (i.e. measuring the change in the acoustic wave amplitude) when using small molecule candidates against protein targets or vesicles. This can provide very valuable information on compounds whose binding induces structural changes in their targets.
In terms of practical workflow improvement and benefits, the eight channels of the dual-chip samX system provide more sensors for a higher throughput, and perhaps even more importantly, provide flexible fluidic channel routing which allows different samples or reagents to be delivered to discrete channels or combinations of channels on the chip. Different proteins can also be immobilised at separate sensor position while the chip is on-line, enabling loading of the surface to full capacity, and allowing for a degree of quantification, which vastly improves data quality and assists interpretation.
Contact Details:
Website: www.saw-instruments.com